Follitropin alfa (Primapur)

DRUG2 trials

Sponsors

IVFarma LLC

Conditions

AbsorptionArea Under CurveInfertility, FemalePharmacokinetics

Phase 1

The Safety and Pharmacokinetics of Primapur and Gonal-f

CompletedNCT03857230

IVFarma LLCAbsorption, Area Under Curve, Pharmacokinetics

Start: 2015-10-29End: 2016-05-10Updated: 2019-08-13

Phase 3

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

CompletedNCT03088137

IVFarma LLCInfertility, Female

Start: 2017-02-08End: 2018-08-17Updated: 2022-04-01

Related Papers

Association of the Serum Folate and Total Calcium and Magnesium Levels Before Ovarian Stimulation With Outcomes of Fresh In Vitro Fertilization Cycles in Normogonadotropic Women

Frontiers in Endocrinology2022-02-1117 citations

A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha.

2019-07-2616 citations

Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®)

Obstetrics Gynecology and Reproduction2018-11-205 citations